دورية أكاديمية

284P Trastuzumab emtansine (T-DM1) in Asian patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC): Data from the phase III EMILIA study.

التفاصيل البيبلوغرافية
العنوان: 284P Trastuzumab emtansine (T-DM1) in Asian patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC): Data from the phase III EMILIA study.
المؤلفون: Im, S-A.1 (AUTHOR), Park, I.2 (AUTHOR), Sohn, J.H.3 (AUTHOR), Im, Y-H.4 (AUTHOR), Lee, S.C.5 (AUTHOR), Chang, H-K.5 (AUTHOR), Macharia, H.6 (AUTHOR), Sun, G.7 (AUTHOR), Lamour, F.8 (AUTHOR), Oh, D-Y.9 (AUTHOR)
المصدر: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS488-S489. 2p.
مصطلحات موضوعية: *METASTATIC breast cancer, *ASIANS, *TRASTUZUMAB
قاعدة البيانات: Academic Search Index
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.08.567